Although BRD9 amplifications occur more frequently in other cancers (Figure 3), the TCGA dataset indicates that BRD9 is the most frequently amplified SWI/SNF gene in cutaneous melanoma, closely followed by BICRAL1, which encodes another ncBAF component (Table 1, Figure 2). Here, BRD9 is linked to cancer.